SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Processing: Top Headlines

No more waiting for the Sun: FTC approves $4bn Ranbaxy acquisition

Sun Pharma closes deal to acquire Ranbaxy for $4bn

30-Mar-2015 - Sun Pharmaceutical Industries has completed its $4bn (€3.7bn) acquisition of Ranbaxy after receiving the thumbs up from the US Federal Trade Commission (FTC).

Related news

News in brief

GMP for excipients: new EU rules on raw materials, packaging, tracking

25-Mar-2015 - The European Commission has published guidelines on GMP excipients after a two-year consultation.

AbbVie bucks Puerto Rico departure trend with $30m expansion

25-Mar-2015 - AbbVie is investing $30m (€27m) in contract manufacturing facilities in Puerto Rico and plans to create 100 jobs over the next two years.

Dispatches from DCAT

Message is clear: Europe is in trouble in terms of pharma growth, experts say

17-Mar-2015 - The European pharma market isn’t likely to deliver much growth over the next five years as generic markets commoditize, IMS Health VP Graham Lewis warned participants at the DCAT (Drug, Chemical & Associated Technologies Association) conference on Monday.

Penn invests in pill tech citing industry demand

11-Mar-2015 - Penn Pharma has added new tablet making technology at its facility in Tredegar, Wales citing drug industry demand for dry granulation manufacturing capacity.

Johnson Matthey builds HPAPI site in Scotland

11-Mar-2015 - API- and catalyst-maker Johnson Matthey has built high containment facilities for potent products at its site in Edinburgh, Scotland.

Sun Pharma goes after opiates with deal to buy GSK’s Aus business

03-Mar-2015 - Indian giant Sun Pharma has bought GSK’s Australian Opiates business.

California bill would require Big Pharma to unveil how drugs are priced

26-Feb-2015 - A new California bill introduced earlier this week would, for the first time, require pharma companies to unveil a number of unique operational costs as a way to better understand drug pricing.

Processing: Featured news

Spotlight

Distributing donated drugs a major challenge says UK neglected diseases group

Distributing donated drugs a major challenge says UK neglected diseases group

More drugs for tropical diseases have been donated since the London declaration of 2012, but getting them...

Novasep to make API for Celladon's heart attack gene therapy
update

Novasep joins Lonza as Mydicar API producer in deal with Celladon

Novasep and Lonza will both make the API for Celladon's heart attack therapy, Mydicar.

Lethal injection drug shortage brings return of firing squad in Utah

Lethal injection drug shortage brings return of firing squad in Utah

Utah will allow execution by firing squad as European pharmaceutical companies refuse to provide drugs for lethal...

Growing elderly population to drive drug excipients sector, study

Growth with aid of Grey: Elderly folks to drive excipients sector, study

Demand for pensioner friendly pills will be an important growth driver for the drug excipients sector according...

WHO calls for proactive strategies to combat falsified, substandard medicines

WHO calls for proactive strategies to combat falsified, substandard medicines

The WHO’s latest report on substandard/spurious/falsely-labelled/falsified/counterfeit (SSFFC) medical products has the organization divvying up certain responsibilities for...

US diabetics pay most for drugs, but world’s poorest bear the biggest economic burden

US diabetics pay most for drugs, but world’s poorest bear the biggest economic burden

Further evidence US diabetics pay more for drugs than sufferers in comparable countries has emerged this month...